May Glymphatic Drainage Improve Life Quality in Progressive Multiple Sclerosis Outpatients?

IF 1.3 Q4 ENGINEERING, BIOMEDICAL
Medical Devices-Evidence and Research Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI:10.2147/MDER.S480815
Sandro Mandolesi, Tarcisio Niglio, Chiara Lenci
{"title":"May Glymphatic Drainage Improve Life Quality in Progressive Multiple Sclerosis Outpatients?","authors":"Sandro Mandolesi, Tarcisio Niglio, Chiara Lenci","doi":"10.2147/MDER.S480815","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The cerebral fluid-dynamic system plays a critical role in maintaining brain health and function. Recent studies identify the glymphatic system as primarily responsible for removing waste products and toxins from brain tissue. In recent years, we have achieved beneficial improvements in MS patients' symptoms and lifestyle using a specific Fluid Dynamic Intensive MAM (FD-MAM) protocol.</p><p><strong>Methods: </strong>We treated 40 outpatients with progressive MS, aged 45-55 years and with EDSS scores from 6 to 9. We applied FD-MAM in 10 daily sessions over two weeks. Before and after glymphatic drainage by FD-MAM, we assessed each patient's clinical status and quality of life using six validated questionnaires.</p><p><strong>Results: </strong>Data from the six validated questionnaires administered to the 40 MS patients show an improvement in 83% of the scores. At the same time, we observed a shift from pathological to physiological values in 50% of the pathological scores after 10 sessions of FD-MAM protocol.</p><p><strong>Conclusion: </strong>This study confirms the positive improvements on life quality in outpatients with progressive multiple sclerosis after one cycle of Fluid Dynamic Intensive MAM (FD-MAM) protocol. Initial follow-up on few patients treated with the FD-MAM protocol suggests that the results persist for six to ten months post-treatment. Future detailed studies, on MS outpatients' larger cohort, are essential to assess the duration of results and its effect on glymphatic system.</p>","PeriodicalId":47140,"journal":{"name":"Medical Devices-Evidence and Research","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531284/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Devices-Evidence and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/MDER.S480815","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The cerebral fluid-dynamic system plays a critical role in maintaining brain health and function. Recent studies identify the glymphatic system as primarily responsible for removing waste products and toxins from brain tissue. In recent years, we have achieved beneficial improvements in MS patients' symptoms and lifestyle using a specific Fluid Dynamic Intensive MAM (FD-MAM) protocol.

Methods: We treated 40 outpatients with progressive MS, aged 45-55 years and with EDSS scores from 6 to 9. We applied FD-MAM in 10 daily sessions over two weeks. Before and after glymphatic drainage by FD-MAM, we assessed each patient's clinical status and quality of life using six validated questionnaires.

Results: Data from the six validated questionnaires administered to the 40 MS patients show an improvement in 83% of the scores. At the same time, we observed a shift from pathological to physiological values in 50% of the pathological scores after 10 sessions of FD-MAM protocol.

Conclusion: This study confirms the positive improvements on life quality in outpatients with progressive multiple sclerosis after one cycle of Fluid Dynamic Intensive MAM (FD-MAM) protocol. Initial follow-up on few patients treated with the FD-MAM protocol suggests that the results persist for six to ten months post-treatment. Future detailed studies, on MS outpatients' larger cohort, are essential to assess the duration of results and its effect on glymphatic system.

淋巴引流可改善进展期多发性硬化症门诊患者的生活质量吗?
背景:脑液动力系统在维持大脑健康和功能方面起着至关重要的作用。最近的研究发现,甘油系统主要负责清除脑组织中的废物和毒素。近年来,我们采用特定的流体动力学强化 MAM(FD-MAM)方案,使多发性硬化症患者的症状和生活方式得到了有益的改善:方法:我们在门诊治疗了 40 名进行性多发性硬化症患者,他们的年龄在 45-55 岁之间,EDSS 评分在 6-9 之间。我们将 FD-MAM 应用于两周内每天 10 次的治疗中。在使用 FD-MAM 进行淋巴引流前后,我们使用六份有效问卷对每位患者的临床状态和生活质量进行了评估:结果:对 40 名多发性硬化症患者进行的六项有效问卷调查数据显示,83% 的评分有所改善。同时,我们还观察到,经过 10 个疗程的 FD-MAM 方案治疗后,50% 的病理评分从病理值转变为生理值:这项研究证实,门诊进行性多发性硬化症患者在接受一个周期的流体动态强化治疗方案(FD-MAM)后,生活质量得到了积极改善。对少数接受 FD-MAM 方案治疗的患者进行的初步随访表明,治疗效果在治疗后六到十个月内仍将持续。今后必须对更多的多发性硬化症门诊病人进行详细研究,以评估疗效的持续时间及其对甘液系统的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Devices-Evidence and Research
Medical Devices-Evidence and Research ENGINEERING, BIOMEDICAL-
CiteScore
2.80
自引率
0.00%
发文量
41
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信